The one drop blood test startup company Genalyte has announced the appointment of their new president Kevin Lo, a former Facebook executive. Lo was associated with Facebook as a senior executive, and was leading the social networking site’s connectivity efforts. He has also worked with Google as General Manager, where he co-founded Google Fiber, their gigabit Internet and TV service provider.
Before he worked at Google, Lo had a stint in the tech and telecom space, including tenures as COO of M2Z Networks and Strategy Consultant at Bain & Co. Lo made his entry in software programming by working as a research assistant at NASA’s Jet Propulsion Laboratory in California. He earned his AB from Harvard University.
“We are at a critical juncture where technology and innovation are driving fundamental changes within our healthcare industry. Genalyte is poised to lead a revolution in real time diagnostics—one that creates better treatment and patient outcomes,” said Lo. “The novel approach using the company’s breakthrough blood diagnostics technology and cloud lab model enables rapid, accurate point of care decisions. I’m excited to join the Genalyte team and help deliver this transformative technology to the health care system.”
Lo is currently serving on the Board of Directors for several companies, which include Benetech, a leading Software for Social Good non-profit and Nominum Inc, an enterprise software security company. He is also a triathlete and he is actively involved in global poverty and health issues.
“We are thrilled to welcome Kevin to our leadership team at a moment of incredible momentum for the company,” said Genalyte CEO and founder Cary Gunn. “Kevin’s unique expertise and experience working with some of the world’s most groundbreaking companies will help guide Genalyte as the company begins this next important chapter in diagnostic innovation.”
Genalyte, the San Diego based startup works on a lab on a chip technology, the company claims that it can run up to 128 different tests on a single prick of blood in under 15 minutes using a program known as Maverick Detection Platform. Their proprietary silicon chips contain range of photonic microring sensors to detect diseases like rheumatoid arthritis. The company raised $92 million in venture funding.